Avanos Medical (AVNS) Retained Earnings (2013 - 2026)

Avanos Medical has disclosed Retained Earnings across 14 years of filings, most recently posting -$36.0 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$36.0 million, up 14.89% year-over-year; the trailing twelve-month figure through Mar 2026 was -$36.0 million (up 14.89% YoY), and the FY2025 annual result was -$32.0 million, up 95.47% from the prior year.
• Retained Earnings came in at -$36.0 million for Q1 2026 at Avanos Medical, down from -$32.0 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$27.0 million in Q4 2023 to a low of -$778.6 million in Q3 2025.
• The 5-year median for Retained Earnings is -$270.0 million (2022), against an average of -$255.3 million.
• Across the five-year window, Retained Earnings tumbled 2518.52% in 2024 and soared 95.47% in 2025, its largest moves.
• Avanos Medical's Retained Earnings stood at -$253.1 million in 2022, then soared by 89.33% to -$27.0 million in 2023, then sank by 2518.52% to -$707.0 million in 2024, then jumped by 95.47% to -$32.0 million in 2025, then declined by 12.5% to -$36.0 million in 2026.
• The last three Retained Earnings figures came in at -$36.0 million (Q1 2026), -$32.0 million (Q4 2025), and -$778.6 million (Q3 2025), per Business Quant data.